European Archives - Page 670 of 1111 - European Medical Journal

Rheumatoid Arthritis Drug to be Repurposed for COVID-19 Therapy in Phase II/III Clinical Trial

The U.S. Department of Human Health and Services’ (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR)…

pandemic

COVID-19 Pandemic Knowledge Course

ES4P’s David Joyce, MD, MBA, and Scott Parazynski, MD, Partner to Offer New Course on Coronavirus Disease (COVID-19)…

Improving access in Africa

There are many notable initiatives in place by pharmaceutical companies to improve access to medicine around the world, especially in hard-to-reach and developing countries.

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S…

Rheumatology in Cyprus amid the COVID-19 pandemic

In March 2020, the COVID-19 pandemic arrived in Cyprus. Suddenly, our lives and our way of life has been affected in an unprecedented way…

parking image

GMB Calls for the Extension of Free Parking for NHS Staff Indefinitely

GMB, the Union for NHS staff, has called for the indefinite extension of the UK governments scheme to suspend NHS staff parking…

National Rosacea Society Reveals New Guidelines on Standard Treatment Options for Rosacea

National Rosacea Society Reveals New Guidelines on Standard Treatment Options for Rosacea

GUIDELINES for the standard treatment options of rosacea, including recommendations for oral therapies, topical therapies, and light-based devices…

New At-Risk Group Identified for Early Melanoma Diagnosis and Treatment

New At-Risk Group Identified for Early Melanoma Diagnosis and Treatment

EVERY YEAR, 197,000 melanoma diagnoses are made globally, and in the UK alone the malignancy constitutes approximately 5% of cancer cases…

Talking to Claire Gillis

GOLD sits down with Claire Gillis, International CEO, WPP Health Practice, who discusses WPP’s work with the ABC Global Alliance, how communications teams can transform patient outcomes, and the proudest moments from her career so far.

EMJ 5.1

EMJ 5.1 2020

Our first flagship journal of 2020, EMJ 5.1, encompasses the most recent developments across a host of highly topical therapeutic fields including…